Don D Sin Selected Research

Multiple Symmetrical Lipomatosis (Lipomatosis, Familial Benign Cervical)

10/2022	Ketogenic diet for mitochondrial disease: potential role in treating the Multiple Symmetric Lipomatosis phenotype associated with the common MT-TK genetic mutation.
1/2020	Self-initiated lifestyle interventions lead to potential insight into an effective, alternative, non-surgical therapy for mitochondrial disease associated multiple symmetric lipomatosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Don D Sin Research Topics

Disease

220	Chronic Obstructive Pulmonary Disease (COPD) 11/2022 - 07/2002
31	Asthma (Bronchial Asthma) 11/2022 - 07/2002
30	Inflammation (Inflammations) 11/2022 - 10/2004
19	Emphysema 01/2022 - 09/2007
16	Lung Neoplasms (Lung Cancer) 12/2020 - 03/2006
12	Pneumonia (Pneumonitis) 05/2022 - 02/2005
11	Lung Diseases (Lung Disease) 01/2022 - 06/2011
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 01/2007
9	COVID-19 01/2022 - 01/2020
9	Airway Remodeling 04/2016 - 01/2011
8	Infections 05/2022 - 02/2006
8	Dyspnea (Shortness of Breath) 01/2020 - 07/2002
7	Cystic Fibrosis (Mucoviscidosis) 10/2019 - 05/2012
6	Atherosclerosis 01/2019 - 01/2007
6	Disease Progression 11/2015 - 10/2007
5	Eosinophilia 06/2022 - 01/2016
5	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2022 - 07/2015
4	Neoplasms (Cancer) 01/2021 - 06/2009
4	Hypoxia (Hypoxemia) 01/2019 - 11/2003
3	Atherosclerotic Plaque (Atheroma) 01/2019 - 11/2012
3	Necrosis 01/2014 - 04/2009
3	Pulmonary Hypertension 01/2012 - 02/2010
3	Obstructive Sleep Apnea 01/2011 - 02/2002
2	Multiple Symmetrical Lipomatosis (Lipomatosis, Familial Benign Cervical) 10/2022 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2022 - 01/2020
2	Virus Diseases (Viral Diseases) 03/2021 - 01/2021
2	Weight Loss (Weight Reduction) 03/2021 - 01/2020
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2021 - 12/2018
2	Pulmonary Arterial Hypertension 12/2018 - 01/2010
2	HIV Infections (HIV Infection) 01/2018 - 05/2014
2	Coronary Disease (Coronary Heart Disease) 07/2015 - 10/2012
2	Bronchiolitis 01/2014 - 05/2013

Drug/Important Bio-Agent (IBA)

70	Biomarkers (Surrogate Marker)IBA 06/2022 - 10/2004
48	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022 - 07/2002
26	Bronchodilator Agents (Bronchodilators)IBA 01/2022 - 07/2002
26	SmokeIBA 01/2021 - 03/2006
22	GoldIBA 04/2021 - 10/2008
20	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2009
14	Pharmaceutical PreparationsIBA 08/2021 - 07/2002
12	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 12/2020 - 10/2007
10	Azithromycin (Zithromax)FDA LinkGeneric 11/2022 - 01/2014
10	Fluticasone (Cutivate)FDA LinkGeneric 05/2022 - 10/2004
10	SteroidsIBA 05/2022 - 07/2002
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 07/2008
8	Biological ProductsIBA 01/2021 - 12/2007
8	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2008
8	Messenger RNA (mRNA)IBA 01/2021 - 01/2013
8	C-Reactive ProteinIBA 01/2018 - 03/2003
7	Immunoglobulin G (IgG)IBA 05/2022 - 09/2013
7	Budesonide (Pulmicort)FDA LinkGeneric 05/2022 - 01/2005
7	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 05/2006
6	Formoterol Fumarate (Oxis)FDA Link 05/2022 - 08/2009
5	Salmeterol Xinafoate (Serevent)FDA Link 05/2022 - 02/2006
5	Particulate MatterIBA 01/2022 - 07/2008
5	Blood Proteins (Serum Proteins)IBA 06/2021 - 06/2009
5	CytokinesIBA 10/2020 - 04/2009
5	Oxygen (Dioxygen)IBA 10/2020 - 11/2003
5	Simvastatin (Zocor)FDA LinkGeneric 10/2020 - 01/2011
5	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 04/2011
4	MacrolidesIBA 12/2021 - 01/2017
3	InflammasomesIBA 01/2022 - 04/2012
3	Granzymes (Granzyme)IBA 12/2020 - 06/2009
3	Prednisone (Sone)FDA LinkGeneric 08/2019 - 04/2009
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 02/2009
3	Carbon MonoxideIBA 01/2016 - 01/2014
3	IgA receptor (protein B)IBA 01/2015 - 01/2013
3	Surface-Active Agents (Surfactants)IBA 01/2015 - 01/2013
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2013 - 07/2008
3	Cholinergic Antagonists (Anticholinergics)IBA 04/2012 - 11/2003
2	Monoclonal AntibodiesIBA 03/2021 - 12/2019
2	LipopolysaccharidesIBA 02/2021 - 01/2016
2	Unithiol (DMPS)IBA 01/2021 - 01/2021
2	Angiotensin-Converting Enzyme 2IBA 12/2020 - 11/2020
2	Serine Proteases (Serine Protease)IBA 12/2020 - 11/2020
2	Gonadal Steroid Hormones (Sex Hormones)IBA 02/2020 - 04/2016
2	Muscarinic AntagonistsIBA 01/2020 - 01/2019
2	Nicotine FDA Link 01/2020 - 10/2015
2	Apolipoproteins E (ApoE)IBA 01/2019 - 08/2017
2	ApolipoproteinsIBA 01/2019 - 08/2017
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 09/2013
2	CholesterolIBA 01/2019 - 01/2015
2	pro-brain natriuretic peptide (1-76)IBA 01/2018 - 02/2010
2	BilirubinIBA 10/2017 - 07/2015
2	AntioxidantsIBA 10/2017 - 07/2015
2	AdiponectinIBA 07/2015 - 10/2012
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2015 - 01/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2014 - 10/2007
2	GlucocorticoidsIBA 06/2014 - 07/2003
2	Peroxidase (Myeloperoxidase)IBA 01/2013 - 01/2012
2	Peptide Hydrolases (Proteases)FDA Link 01/2012 - 06/2009

Therapy/Procedure

52	Therapeutics 11/2022 - 02/2002
6	Precision Medicine 01/2020 - 01/2017
5	Vascular Surgical Procedures 05/2010 - 10/2008
3	Lung Transplantation 01/2022 - 10/2011
3	Artificial Respiration (Mechanical Ventilation) 03/2021 - 11/2003
3	Drug Therapy (Chemotherapy) 10/2014 - 09/2006
2	Telerehabilitation 01/2022 - 01/2021
2	Length of Stay 01/2017 - 10/2008
2	Nebulizers and Vaporizers (Inhaler) 09/2015 - 04/2009
2	Highly Active Antiretroviral Therapy (HAART) 05/2014 - 01/2014